Treatment adherence and quality of life in UK distal renal tubular acidosis patients

Previous PostThe global early access programme landscape and its application to cell and gene therapies
Next PostCost-effectiveness analysis of using hypoxic stored red blood cells to reduce the frequency of blood transfusions